Share Lexicon Pharmaceuticals Sets Sights on Heart Trial Results, Diabetes Drug Resubmission in 2027

MarketBeat · LXRX · November 20, 2026

Lexicon Pharmaceuticals Sets Sights on Heart Trial Results, Diabetes Drug Resubmission in 2027

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: MarketBeat ↗